[go: up one dir, main page]

MY127711A - Anti-vaginitis compositions for topical use - Google Patents

Anti-vaginitis compositions for topical use

Info

Publication number
MY127711A
MY127711A MYPI97002126A MYPI9702126A MY127711A MY 127711 A MY127711 A MY 127711A MY PI97002126 A MYPI97002126 A MY PI97002126A MY PI9702126 A MYPI9702126 A MY PI9702126A MY 127711 A MY127711 A MY 127711A
Authority
MY
Malaysia
Prior art keywords
vaginitis
compositions
topical use
benzocaine
miconazole
Prior art date
Application number
MYPI97002126A
Inventor
Embil Koral
Morton Oswald
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY127711(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of MY127711A publication Critical patent/MY127711A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION IN THE TREATMENT OF VAGINITIS COMPRISING ONE OR MORE ANTI-VAGINITIS MEDICAMENTS SUCH AS METRONIDAZOLE AND MICONAZOLE AND ONE OR MORE LOCAL ANAESTHETICS SUCH AS LIDOCAINE OR BENZOCAINE.
MYPI97002126A 1996-05-17 1997-05-15 Anti-vaginitis compositions for topical use MY127711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MY127711A true MY127711A (en) 2006-12-29

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97002126A MY127711A (en) 1996-05-17 1997-05-15 Anti-vaginitis compositions for topical use

Country Status (12)

Country Link
EP (1) EP0910377A1 (en)
JP (1) JP2000513334A (en)
CN (1) CN1127338C (en)
AU (1) AU2905597A (en)
BR (1) BR9709316A (en)
GB (1) GB9610359D0 (en)
ID (1) ID16929A (en)
MY (1) MY127711A (en)
RU (1) RU2195281C2 (en)
TR (1) TR199802351T2 (en)
WO (1) WO1997044032A1 (en)
ZA (1) ZA974266B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
WO2005027807A1 (en) 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
EP1909752A2 (en) * 2005-05-09 2008-04-16 Drugtech Corporation Modified-release pharmaceutical compositions
CN1291754C (en) * 2005-07-12 2006-12-27 李赴朝 Localized anesthesia synergistic delay agent
JP2009522360A (en) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション Composition and method of use thereof
AU2006332520A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
RU2605343C1 (en) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
RU2603490C1 (en) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
HRP20210762T1 (en) 2016-07-08 2021-06-25 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. PHARMACEUTICAL PREPARATION CONTAINING BENZIDAMINE
TR2023017366A1 (en) * 2023-12-15 2025-06-23 Bilensoy Ibrahim Tamer BIOADHESIONAL VAGINAL PHARMACEUTICAL SYSTEMS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
RU2029548C1 (en) * 1989-07-07 1995-02-27 Центр по химии лекарственных средств Antimicrobial or radiosensibilizing agent
GB9318641D0 (en) * 1993-09-08 1993-10-27 Edko Trading Representation Compositions

Also Published As

Publication number Publication date
WO1997044032A1 (en) 1997-11-27
ID16929A (en) 1997-11-20
BR9709316A (en) 2000-05-02
AU2905597A (en) 1997-12-09
JP2000513334A (en) 2000-10-10
ZA974266B (en) 1998-11-16
RU2195281C2 (en) 2002-12-27
CN1223581A (en) 1999-07-21
CN1127338C (en) 2003-11-12
TR199802351T2 (en) 1999-03-22
EP0910377A1 (en) 1999-04-28
GB9610359D0 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
MY127711A (en) Anti-vaginitis compositions for topical use
MY119403A (en) Novel compounds with analgesic effect.
GB2340039B (en) Improved delivery of drugs to mucosal surfaces
AU1890295A (en) Piperidines and pyrrolidines
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
MY119365A (en) Novel pharmaceutical combination
CA2239174A1 (en) Novel compounds with analgesic effect
ATE285237T1 (en) COMPOSITION CONTAINING TRAMADOL AND A NON-STEROID ANTI-INFLAMMATORY AGENT
AU2931500A (en) Pharmaceutical composition containing nitrate source and an acidifying agent fortreating skin ischaemia
MD960330A (en) Nonpeptidyl compounds, pharmaceutical composition on base thereof, treatment process
ES2161288T3 (en) COMPRESSED CLOSED WITH POLYMER THAT INCLUDES AMOXYCLINE AND CLAVULANATE.
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
ZA872120B (en) Pharmaceutical composition
LT2001041A (en) Stable liquid formulations of botulinum toxin
IL108327A (en) Pharmaceutical composition comprising 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
PL330865A1 (en) Agents containing lectins and their application
AU9731198A (en) Histogranin peptide and their analgesic use
EP0161816A3 (en) Urogastrone
AU2104900A (en) Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine
AU1026399A (en) Pharmaceutical compositions containing ricinoleic acid and their use in anti-inflammatory and analgesic therapy
HUT74460A (en) Pharmaceutical composition for psoriasis treatment
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
WO1999003509A3 (en) Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology
ES2059264A1 (en) Utilization of nitrovaso-dilators in the preparation of anti-inflammatory and analgesic medicaments of topical use
AR006437A1 (en) USE OF N- MONOHYDROCHLORIDE (ENDO-9-METHYL-9-AZABICICLO [3.3.1] NON-3-IL) -1- METHYLIMIDAZOLE-3-CARBOXAMIDE, FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROPHYLAXIS OF DIARRHEA AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS IT